CRH Delivers Strong Q2 2026 Results and Reaffirms Full-Year Outlook
CRH is trading near its 52-week low of $93.58 (11% above the low).
Summary
CRH posted Q2 2026 revenue of $10.8B (+6% YoY) and net income of $1.5B (+13% YoY), reaffirmed FY26 guidance, and suspended share buybacks to focus on the pending $8.5B Arcosa acquisition.
Key Events · Earnings and Guidance · CRH
-
Q2 Revenue and Earnings Growth
Total revenues rose 6% to $10.8B, net income increased 13% to $1.5B, and Adjusted EBITDA grew 7% to $2.6B, with margins expanding across segments.
-
FY26 Guidance Reaffirmed
Management reiterated 2026 guidance for Net income of $3.9B-$4.1B, Adjusted EBITDA of $8.1B-$8.5B, and Diluted EPS of $5.60-$6.05, citing favorable demand trends.
-
Capital Allocation Update
Share buyback program suspended to prioritize the $8.5B Arcosa acquisition; $0.7B in shares repurchased YTD. Quarterly dividend raised 5% to $0.39 per share.
-
Active Portfolio Management
Completed 11 acquisitions for $1.1B in Q2, including Axius Water for $0.7B, and divested three non-core businesses for $1.7B in proceeds.
Analysis · CRH · Manufacturing
A 6% revenue increase and 13% net income growth in Q2 underscore the power of pricing and acquisitions. Reaffirming the full-year outlook signals management's confidence even as macroeconomic uncertainty lingers. The decision to suspend share buybacks in favor of the $8.5B Arcosa acquisition marks a notable shift in capital allocation, while the 5% dividend hike reinforces a commitment to shareholder returns. Net debt climbed to $15.4B, reflecting acquisition spending, but the balance sheet remains investment-grade with ample liquidity.
At the time of this filing, CRH was trading at $103.58 on NYSE in the Manufacturing sector, with a market capitalization of approximately $66.6B. The 52-week trading range was $93.58 to $131.55. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.